Specifically, IL-10 was found to be necessary for preventing hypertriglyceridemia and mitigating adverse cardiac effects, such as impaired glucose oxidation, ectopic lipid accumulation (cardiac steatosis), and ventricular stretching. Here, IL10 is linked to hypertriglyceridemia.